ADMA Biologics, Inc. (ADMA)

ADMA Biologics Revenue

ADMA Biologics had revenue of $114.49M in the quarter ending March 31, 2026, a decrease of -0.27%. This brings the company's revenue in the last twelve months to $509.86M, up 10.99% year-over-year. In the year 2025, ADMA Biologics had annual revenue of $510.17M with 19.63% growth.

• Revenue (ttm): $509.86M
• Revenue Growth: +10.99%
• P/S Ratio: 3.75
• Revenue / Employee: $788,043
• Employees: 647
• Market Cap: 1.91B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	510.17M	83.72M	19.63%
Dec 31, 2024	426.45M	168.24M	65.15%
Dec 31, 2023	258.22M	104.14M	67.59%
Dec 31, 2022	154.08M	73.14M	90.36%
Dec 31, 2021	80.94M	38.72M	91.72%
Dec 31, 2020	42.22M	12.87M	43.85%
Dec 31, 2019	29.35M	12.36M	72.79%
Dec 31, 2018	16.99M	-5.78M	-25.37%
Dec 31, 2017	22.76M	12.10M	113.49%
Dec 31, 2016	10.66M	3.48M	48.53%
Dec 31, 2015	7.18M	1.26M	21.33%
Dec 31, 2014	5.92M	2.85M	92.84%
Dec 31, 2013	3.07M	1.95M	174.35%
Dec 31, 2012	1.12M	357.08K	46.92%
Dec 31, 2011	761.04K	-	-
Jun 30, 2011	-	-	-
Dec 31, 2010	-	-	-
Jun 30, 2010	-	-	-
Jun 30, 2009	-	-	-
Jun 30, 2008	-	-	-

Data Source: Fiscal.ai Last updated: May 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 22, 2026

Data Sources Report a data error